Alcoholism
Researchers from University Hospital provide details of new studies and findings in the area of alcoholism
Published in Oncology Business Week, June 8th, 2008
"IKK2 plays a key role in the development of NASH by mediating inflammation and insulin resistance. Here the beneficial effects of a pharmacological IKK2 inhibitor (AS602868) on initial stages of NASH progression were tested. Mice were fed with a high sucrose diet (HSD) and daily-administered AS602868 and vehicle. The impact of AS602868 on NASH progression was studied using biochemical, histological and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Abraxis BioScience, Inc.
Abraxis BioScience Reports 14% Revenue Growth to $82.1 Million for the First Quarter of 2008 - Abraxis BioScience, Inc.
New Data Highlighting the Potential Utility of ABRAXANE in Combination with Targeted Therapies and Other Chemotherapeutic Agents to Be Presented at ASCO - ActiveStrategy, Inc.
Oakwood Healthcare System Selects ActiveStrategy for Balanced Scorecard Software, Consulting - Acute Myeloid Leukemia
Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia - Adenocarcinoma Genetics
Scientists at Memorial Sloan Kettering Cancer Center, Department of Pathology publish new data on adenocarcinoma genetics - Advaxis, Inc.
Advaxis Files Investigational New Drug Application with U.S. Food and Drug Administration - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
